Table 1.
Inducer | Concentration | Effect | Direction of differentiation | Reference |
---|---|---|---|---|
Dexamethasone + 3-isobutyl-1-methylxanthine + insulin | 1 μM 0.5 mM 0.01 mg/ml |
Increase fat deposition in the cytoplasm | Adipocytes | (Yu et al., 2012) |
Ascorbic acid + dexamethasone | 50 μM 100 nM |
Increases the activity of alkaline phosphatase | Osteocytes | (Yu et al., 2012) |
TGF- β1 + ascorbic acid + dexamethasone | 10 ng/ml 50 μg/ml 100 nM |
Chondrocytes | (Vater et al., 2011) | |
TGF-β1 | 1, 2, 5 and 10 ng/ml | Stimulate SMC-specific genes expression | Smooth muscle cells | (Vater et al., 2011; Floren et al., 2016) |
5-azacytidine | 3 μM 10 μM |
Inhibits DNA methyltransferase | Cardiomyocytes | (Yamada et al., 2007; Rowlands et al., 2008; Wei et al., 2011)) |
VEGF | 10, 50 ng/ml | Phosphorylate VEGF-RII and increase its Activity | Endothelial | (Pankajakshan et al., 2013; Vater et al., 2011) |